血清阳性类风湿关节炎的家族性风险及其与吸烟的交互作用:一项基于人群的队列研究
该研究利用韩国国民健康保险与健康筛查数据库,纳入2002至2018年间5524403名有一级亲属的个体,评估血清阳性类风湿关节炎的家族性风险及家族史与吸烟的交互作用。一级亲属患病者的发病风险为无患病一级亲属者的4.52倍(95%CI 3.98,5.12),调整生活方式后略降至HR 4.49。吸烟与家族史的联合效应高于两者单独效应之和但未达统计学显著(RERI 1.30,95%CI ‒0.92,3.51),重度吸烟者与家族史交互作用更突出(RERI 4.13,95%CI ‒0.88,9.13),提示剂量-反应交互模式。
要点
- 一级亲属患血清阳性RA者发病风险为无患病一级亲属者的4.52倍(95%CI 3.98,5.12)。
- 调整生活方式因素后家族性风险仅略降(HR 4.49),提示遗传因素是家族聚集的主要驱动因素。
- 重度吸烟者(HR 1.92,95%CI 1.70,2.18)风险高于中度吸烟者(HR 1.15,95%CI 1.04,1.28)。
核心结论
- 研究结果提示RA相关基因与吸烟之间可能存在交互作用。
- 家族性风险在调整生活方式因素后仅略有下降(HR 4.49),提示遗传因素是RA家族聚集的主要驱动因素。
研究设计与样本
- 基于国民健康保险与健康筛查项目数据库的人群队列研究,纳入2002至2018年间5524403名有一级亲属的个体,数据库包含家族关系与生活方式因素信息。
- 采用风险比(HR)及95%CI比较有一级亲属患病与无一级亲属患病个体的发病风险,并在相加尺度上采用相对超额风险因交互作用(RERI)评估吸烟与家族史的交互作用。
主要发现
- 有一级亲属患病者发病风险为无患病一级亲属者的4.52倍(95%CI 3.98,5.12)。
- 调整生活方式因素后家族性风险略降(HR 4.49)。
- 吸烟与发病风险升高相关,重度吸烟者(HR 1.92,95%CI 1.70,2.18)较中度吸烟者(HR 1.15,95%CI 1.04,1.28)更为明显。
- 交互分析中吸烟与家族史的联合效应高于两者单独效应之和,但未达统计学显著(RERI 1.30,95%CI ‒0.92,3.51)。
- 有家族史的重度吸烟者交互作用突出(RERI 4.13,95%CI ‒0.88,9.13),超过中度吸烟者(RERI 0.61,95%CI ‒1.90,3.13),提示剂量-反应交互模式。
关键数值与推荐
- 有一级亲属患病者较无患病一级亲属者发病风险HR 4.52(95%CI 3.98,5.12)。
- 调整生活方式因素后家族性风险HR 4.49。
- 重度吸烟者HR 1.92(95%CI 1.70,2.18),中度吸烟者HR 1.15(95%CI 1.04,1.28)。
- 吸烟与家族史交互作用RERI 1.30(95%CI ‒0.92,3.51),未达统计学显著。
- 有家族史的重度吸烟者RERI 4.13(95%CI ‒0.88,9.13),中度吸烟者RERI 0.61(95%CI ‒1.90,3.13)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We evaluated the familial risk of seropositive rheumatoid arthritis (RA) and examined interactions between family history and smoking. METHODS: Using the National Health Insurance and Health Screening Program databases, which include information on familial relationships and lifestyle factors, we identified 5 524 403 individuals with first-degree relatives (FDRs) from 2002-2018. We calculated familial risk using hazard ratios (HRs) with 95% CIs which compare the risk of individuals with and without affected FDRs. Interactions between smoking and family history were assessed on an additive scale using the relative excess risk due to interaction (RERI). RESULTS: Individuals with affected FDR had 4.52-fold (95% CI 3.98, 5.12) increased risk of disease compared with those with unaffected FDR. Familial risk adjusted for lifestyle factors decreased slightly (HR 4.49), suggesting that a genetic contribution is the predominant driver in the familial aggregation of RA. Smoking was associated with an increased risk of disease that was more pronounced among heavy (HR 1.92 95% CI 1.70, 2.18) compared with moderate (HR 1.15 95% CI 1.04, 1.28) smoking. In the interaction analysis, the risk associated with the combined effect of smoking and family history was higher than the sum of their individual effects, though statistically non-significant (RERI 1.30 95% CI ‒0.92, 3.51). Heavy smokers with a positive family history showed a prominent interaction (RERI 4.13 95% CI ‒0.88, 9.13) which exceeded moderate smokers (RERI 0.61 95% CI ‒1.90, 3.13), suggesting a dose-response interaction pattern. CONCLUSION: Our findings indicate the possibility of an interaction between RA-associated genes and smoking.
引用
- Kim HJ, Swan H, Kazmi SZ, et al. Familial risk of seropositive rheumatoid arthritis and interaction with smoking: a population-based cohort study. Rheumatology (Oxford). 2023. PMID: 36692153. doi:10.1093/rheumatology/kead048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。